AeroLeads people directory · profile

Junxia W. Email & Phone Number

Cell Therapy R&D and Global Drug Product Development at Catalent Pharma Solutions
Location: Greater Boston, United States, United States 9 work roles 3 schools
LinkedIn matched
✓ Verified May 2026 3 data sources Profile completeness 86%

Contact Signals

LinkedIn Profile matched
3 free lookups remaining · No credit card
Current company
Catalent Pharma Solutions
Role
Cell Therapy R&D and Global Drug Product Development
Location
Greater Boston, United States, United States
Company size
8864 employees

Who is Junxia W.? Overview

A concise factual answer block for searchers comparing this professional profile.

Quick answer

Junxia W. is listed as Cell Therapy R&D and Global Drug Product Development at Catalent Pharma Solutions, a company with 8864 employees, based in Greater Boston, United States, United States. AeroLeads shows a matched LinkedIn profile for Junxia W..

Junxia W. previously worked as Head, Cell Therapy Global Product Development at Catalent Pharma Solutions and Sr. Director, Cell Therapy, Cyto Innovation at Resilience. Junxia W. holds Postdoctoral Fellow - Bwh, Bidmc, Immunology, Cancer Biology from Harvard Medical School.

Company email context

Email format at Catalent Pharma Solutions

This section adds company-level context without repeating Junxia W.'s masked contact details.

Catalent Pharma Solutions

Review company-level records connected to Junxia W. before choosing the right outreach path.

View email format View company profile Management contacts
Profile bio

About Junxia W.

A physician scientist, an immunologist and a pharmacologist by training with a broad range of early and late phase drug development experience. Development of target product profile experience. Strong knowledge of regulatory, Immunology, Oncology, Hematology therapeutic areas with experience in diverse biological mechanisms. Strong knowledge of the evolving clinical landscape in Hematology Oncology, Immunology, Cell and Gene Therapy, focused on B-cell Acute Lymphoblastic Leukemia (ALL), Acute Myeloid Leukemia (AML), B-cell Non-Hodgkin Lymphomas (NHL), Multiple myeloma (MM), Diffuse large B-cell lymphoma (DLBCL), X-Linked Severe Combined Immunodeficiency (XSCID), Chimeric Antigen Receptor (CAR) T-cell, stem cell gene therapy, and AAV gene therapies. GMP and GCP validation, clinical biomarkers, immunogenicity, clinical development and manufacturing of CAR T-cell therapies, CD34 stem cell therapies and induced Pluripotent Stem Cell (iPSC). Led functional genomics, bioinformatics, translational research, small molecule screening, in vitro and in vivo efficacy. Experienced in cross-functional interfaces with site engineers, facility, EHS, IT, digital, legal, HR/talent development, procurement, process development, analytical development, manufacturing, clinical pharmacology, clinical operations, regulatory, CAP CLIA, QA, QC, GMP operations. Advanced knowledge of industry standards, FDA and ICH regulations applicable to development and validation, clinical trial, biomarkers, process and analytical development.

Current workplace

Junxia W.'s current company

Company context helps verify the profile and gives searchers a useful next step.

Catalent Pharma Solutions
Catalent Pharma Solutions
Cell Therapy R&D and Global Drug Product Development
somerset, new jersey, united states
Website
catalent.com
Employees
8864
AeroLeads page
Company profile
View company profile Email format
9 roles · 10 years

Junxia W. work experience

A career timeline built from the work history available for this profile.

Head, Cell Therapy Global Product Development

Current
Catalent Pharma Solutions

Belgium, Princeton NJ, Boston

Jun 2023 - Present

Sr. Director, Cell Therapy, Cyto Innovation

Resilience

Responsible for the development and execution of cell therapy strategies for immunotherapy, stem cell therapy and regenerative medicine programs, focusing on evaluating new technologies and developing next generation cellular therapy platform, such as induced Pluripotent Stem Cells (iPSC).Built a Cyto Innovation R&D pilot lab and group at Waltham, MA to.

2021 - 2023 ~2 yrs

Senior Director

Mustang Bio

Achieved three successful US IND filings for cellular therapies including two CAR T cell therapies and one stem cell therapy (0 to 3). Built systems, processes and labs in support of CMC and Clinical Development of 8 cell and gene therapy programs for oncology and rare disease indications. Built and expanded an analytical organization to 3 teams to support.

Jan 2020 - May 2021

Director

Mustang Bio

Greater Boston Area

Strategic planning and management of analytical activities for preclinical and clinical Chimeric Antigen Receptor (CAR) T-cell programs and X-linked severe combined immunodeficiency (XSCID) stem cell gene therapy programs.Analytical Development and Clinical Science- Established in-house Analytical capability of Flow cytometry, ddPCR, qPCR, QC microbiology.

Jan 2018 - Dec 2019

Associate Director

Editas Medicine

Greater Boston Area

Preclinical safety evaluation of genome editing (CRISPR/Cas9) programs with a focus on immunogenicity.- Established in-house bioanalytical capability of ELISpot, Luminex, ELISA, Flow cytometry assays in support of immunogenicity studies in non-human primates and humans.- Hired, trained and mentored direct reports.- Designed and developed immunogenicity.

2016 - 2017 ~1 yr

Fellow, Cell And Gene Therapy

Novartis

Greater Boston Area

Analytical development and clinical biomarker strategy to predict manufacturing success and/or clinical outcome for cellular therapy.

Apr 2016 - Oct 2016

Principal Scientist, Cell And Gene Therapy

Novartis

Greater Boston Area

Analytical Development and Quality Management- Designed and developed analytical assays and workflows for Chimeric Antigen Receptor (CAR) T-cell therapy (KYMRIA). - Spearheaded CyTOF projects for WBC/tumor characterization in cellular therapy clinical trials.- Managed quality standards and quality related issues.Project Management- Managed a project to.

Nov 2014 - Mar 2016

Adjunct Faculty, Instructor In Medicine (Part-Time)

Harvard Medical School

Greater Boston Area

Director: Carl Rosow, M.D.A teaching faculty - 2015 Principles of Pharmacology courseA teaching faculty - 2014 Principles of Pharmacology course

Feb 2015 - Jun 2016

Associate Immunologist At Brigham And Women'S Hospital, Instructor In Medicine At Hms

Bwh, Harvard Medical School

Greater Boston Area

Report to Peter Nigrovic, M.D. and Michael Brenner, M.D.Conducted research on novel biomarkers/targets for inflammatory arthritis.- Immunophenotypic studies of myeloid cells in patients using flow cytometry and CyTOF mass cytometry- Cell sorting and gene profiling using QPCR array- Expression of GFP tagged protein in differentiated myeloid cell lines.

Apr 2013 - Oct 2014
Team & coworkers

Colleagues at Catalent Pharma Solutions

Other employees you can reach at catalent.com. View company contacts for 8864 employees →

MA Melody Amato Melody Amato Colleague at Catalent Pharma SolutionsBedford, Indiana, United States, United States View → PA Paul Anderson Paul Anderson Colleague at Catalent Pharma SolutionsBloomington, Indiana, United States, United States View → SC Stefano Cavallotti Stefano Cavallotti Colleague at Catalent Pharma SolutionsMilan, Lombardy, Italy, Italy View → RK Rachel Karpastias Rachel Karpastias Colleague at Catalent Pharma SolutionsBeverly Hills, California, United States, United States View → TB Tamatha Baxley Tamatha Baxley Colleague at Catalent Pharma SolutionsGreenville, North Carolina, United States, United States View → LC Louis Clark Louis Clark Colleague at Catalent Pharma SolutionsWinterville, North Carolina, United States, United States View → JB Jeff Browne Jeff Browne Colleague at Catalent Pharma SolutionsOldsmar, Florida, United States, United States View → AD Axelle Deroubaix Axelle Deroubaix Colleague at Catalent Pharma SolutionsBrussels Metropolitan Area, Belgium View → GP Gaurangkumar Patel Gaurangkumar Patel Colleague at Catalent Pharma SolutionsStrathroy, Ontario, Canada, Canada View → MM Mia Moon Mia Moon Colleague at Catalent Pharma SolutionsGreater Bloomington Area, United States View →
3 education records

Junxia W. education

Postdoctoral Fellow - Bwh, Bidmc, Immunology, Cancer Biology

Harvard Medical School

Advisors: Peter Nigrovic, M.D., Roya Khosravi-Far, Ph.D. Conducted research on innate immune cell types in autoimmune diseases. Conducted.

Ph.D., Pharmacology - Shanghai Institute Of Materia Medica

University Of Chinese Academy Of Sciences

Activities and Societies: Immunosuppressive agents, autoimmune disease/inflammation, bone marrow transplantation, arthritis, lupus, herb.

M.D., Medicine

Medical College In Tianjin

1/1998 – 7/1999: Clinical rotations in Tianjin Third Central Hospital, Tianjin, China

FAQ

Frequently asked questions about Junxia W.

Quick answers generated from the profile data available on this page.

What company does Junxia W. work for?

Junxia W. works for Catalent Pharma Solutions.

What is Junxia W.'s role at Catalent Pharma Solutions?

Junxia W. is listed as Cell Therapy R&D and Global Drug Product Development at Catalent Pharma Solutions.

Where is Junxia W. based?

Junxia W. is based in Greater Boston, United States, United States while working with Catalent Pharma Solutions.

What companies has Junxia W. worked for?

Junxia W. has worked for Catalent Pharma Solutions, Resilience, Mustang Bio, Editas Medicine, and Novartis.

Who are Junxia W.'s colleagues at Catalent Pharma Solutions?

Junxia W.'s colleagues at Catalent Pharma Solutions include Melody Amato, Paul Anderson, Stefano Cavallotti, Rachel Karpastias, and Tamatha Baxley.

How can I contact Junxia W.?

You can use AeroLeads to view verified contact signals for Junxia W. at Catalent Pharma Solutions, including work email, phone, and LinkedIn data when available.

What schools did Junxia W. attend?

Junxia W. holds Postdoctoral Fellow - Bwh, Bidmc, Immunology, Cancer Biology from Harvard Medical School.

Find 750M verified contacts

Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.